Deanol
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Deanol
- DrugBank Accession Number
- DB13352
- Background
Deanol is commonly referred to as 2-(dimethylamino)ethanol, dimethylaminoethanol (DMAE) or dimethylethanolamine (DMEA). It holds tertiary amine and primary alcohol groups as functional groups. Deanol has been used in the treatment of attention deficit-hyperactivity disorder (ADHD), Alzheimer's disease, autism, and tardive dyskinesia. It has been also used as an ingredient in skin care, and in cognitive function- and mood-enhancing products.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 89.1362
Monoisotopic: 89.084063979 - Chemical Formula
- C4H11NO
- Synonyms
- 2-(dimethylamino)ethanol
- Dimethylethanolamine
- External IDs
- NSC-2652
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your software1,2-Benzodiazepine The risk or severity of CNS depression can be increased when 1,2-Benzodiazepine is combined with Deanol. Acenocoumarol The risk or severity of adverse effects can be increased when Deanol is combined with Acenocoumarol. Acetazolamide The risk or severity of CNS depression can be increased when Acetazolamide is combined with Deanol. Acetophenazine The risk or severity of CNS depression can be increased when Acetophenazine is combined with Deanol. Agomelatine The risk or severity of CNS depression can be increased when Agomelatine is combined with Deanol. - Food Interactions
- Not Available
Categories
- ATC Codes
- N06BX04 — Deanol
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 1,2-aminoalcohols. These are organic compounds containing an alkyl chain with an amine group bound to the C1 atom and an alcohol group bound to the C2 atom.
- Kingdom
- Organic compounds
- Super Class
- Organic nitrogen compounds
- Class
- Organonitrogen compounds
- Sub Class
- Amines
- Direct Parent
- 1,2-aminoalcohols
- Alternative Parents
- Trialkylamines / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives
- Substituents
- 1,2-aminoalcohol / Alcohol / Aliphatic acyclic compound / Hydrocarbon derivative / Organic oxygen compound / Organooxygen compound / Organopnictogen compound / Primary alcohol / Tertiary aliphatic amine / Tertiary amine
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- tertiary amine, ethanolamines (CHEBI:271436)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2N6K9DRA24
- CAS number
- 108-01-0
- InChI Key
- UEEJHVSXFDXPFK-UHFFFAOYSA-N
- InChI
- InChI=1S/C4H11NO/c1-5(2)3-4-6/h6H,3-4H2,1-2H3
- IUPAC Name
- 2-(dimethylamino)ethan-1-ol
- SMILES
- CN(C)CCO
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0032231
- PubChem Compound
- 7902
- PubChem Substance
- 347829294
- ChemSpider
- 13854944
- BindingDB
- 50060526
- 3116
- ChEBI
- 271436
- ChEMBL
- CHEMBL1135
- ZINC
- ZINC000001641058
- Wikipedia
- Dimethylethanolamine
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1400.0 mg/mL ALOGPS logP -0.46 ALOGPS logP -0.5 Chemaxon logS 1.2 ALOGPS pKa (Strongest Acidic) 15.59 Chemaxon pKa (Strongest Basic) 9.03 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 23.47 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 26.28 m3·mol-1 Chemaxon Polarizability 10.5 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 111.1924745 predictedDarkChem Lite v0.1.0 [M-H]- 111.1191745 predictedDarkChem Lite v0.1.0 [M-H]- 110.9997745 predictedDarkChem Lite v0.1.0 [M-H]- 111.1613745 predictedDarkChem Lite v0.1.0 [M-H]- 119.91006 predictedDeepCCS 1.0 (2019) [M+H]+ 111.6006745 predictedDarkChem Lite v0.1.0 [M+H]+ 111.7146745 predictedDarkChem Lite v0.1.0 [M+H]+ 111.6260745 predictedDarkChem Lite v0.1.0 [M+H]+ 111.7314745 predictedDarkChem Lite v0.1.0 [M+H]+ 122.1496 predictedDeepCCS 1.0 (2019) [M+Na]+ 111.1876745 predictedDarkChem Lite v0.1.0 [M+Na]+ 111.0631745 predictedDarkChem Lite v0.1.0 [M+Na]+ 111.0001745 predictedDarkChem Lite v0.1.0 [M+Na]+ 111.0614745 predictedDarkChem Lite v0.1.0 [M+Na]+ 130.45183 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:40 / Updated at June 12, 2020 16:53